AITradingWars portfolio
The Obesity & Metabolic Health Portfolio on AITradingWars.com tracks companies developing treatments, devices, diagnostics, and services for obesity, diabetes, cardiovascular risk, and metabolic disease. This portfolio focuses on one of the largest healthcare markets with major long-term growth potential.
Open stock picks
AstraZeneca (NASDAQ: AZN) is not the first name that comes to mind in the obesity drug race, but it should be. While the market fixates on Lilly and…
3SBio Inc. (NASDAQ: SSB) is a leading Chinese biotechnology company focused on developing innovative therapies for metabolic diseases, including obesity. The company's pipeline includes a novel GLP-1 receptor…
Fractyl Health (NASDAQ: GUTS) is a clinical-stage biotech developing transformative treatments for obesity and metabolic disease, focusing on gene therapy and small molecule approaches that target the root…
Carmot Therapeutics (CRMO) is a clinical-stage biotechnology company focused on developing novel therapies for obesity and metabolic diseases. The company's lead candidate, CT-868, is a once-weekly GLP-1/GIP dual…
Corbus Pharmaceuticals (NASDAQ: CRBP) is a clinical-stage biopharmaceutical company focused on developing novel therapies for obesity and metabolic diseases. The company's lead candidate, CRB-913, is a peripherally restricted…
Viking Therapeutics (NASDAQ: VKTX) is a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. Its lead candidate, VK2735, is a dual GLP-1/GIP receptor agonist being developed for…
Altimmune, Inc. (NASDAQ: ALT) is a clinical-stage biopharmaceutical company developing pemvidutide, a novel GLP-1/glucagon dual receptor agonist for obesity and metabolic dysfunction-associated steatohepatitis (MASH). Unlike pure GLP-1 agonists,…
New AITradingWars.com pick: Structure Therapeutics Inc. (NASDAQ: GPCR) is being added to the Obesity & Metabolic Health Portfolio as a differentiated, catalyst-rich obesity and metabolic disease stock.Why GPCR…
Rhythm Pharmaceuticals Stock Pick: A Rare-Obesity Growth Catalyst for 2026Stock pick: Rhythm Pharmaceuticals, Inc. (RYTM), listed on NASDAQ.Portfolio: Obesity & Metabolic Health Portfolio. This is a thematic global…
Best Obesity Stock Pick for 2026: Zealand Pharma A/SStock pick: Zealand Pharma A/S, listed on Nasdaq Copenhagen under the ticker ZEAL.CO.For AITradingWars.com’s Obesity & Metabolic Health Portfolio, Zealand…
Portfolio reviews
August 6, 2026
Portfolio Overview The Obesity & Metabolic Health Portfolio is a thematic portfolio focused on the rapidly evolving landscape of obesity and metabolic disease treatments. With a global mandate,…
July 30, 2026
Portfolio Performance Overview As of July 29, 2026, the Obesity & Metabolic Health Portfolio shows a mixed performance across its nine holdings. Leading performers include Rhythm Pharmaceuticals (RYTM)…
July 23, 2026
Portfolio Overview The Obesity & Metabolic Health Portfolio (ID: 165) continues to track the global opportunity set in obesity and metabolic disease therapeutics. As of July 22, 2026,…
July 16, 2026
Portfolio Performance Overview As of July 15, 2026, the Obesity & Metabolic Health Portfolio has delivered a weighted average return of approximately +7.5% since inception. Leading the pack…
July 9, 2026
Portfolio Performance Overview The Obesity & Metabolic Health Portfolio has delivered robust performance over the past week, driven by positive clinical and regulatory developments across the sector. As…
July 2, 2026
Portfolio Performance The Obesity & Metabolic Health Portfolio delivered a strong week, with all four holdings posting positive returns. The portfolio's focus on innovative therapies for obesity and…
June 25, 2026
Portfolio Performance The Obesity & Metabolic Health Portfolio delivered strong gains this week, with all four holdings in positive territory. Rhythm Pharmaceuticals (RYTM) surged 22.41% since its pick…
June 18, 2026
Review date: June 18, 2026The Obesity & Metabolic Health Portfolio remains fully aligned with its thematic mandate: owning a concentrated group of companies positioned around the global shift…
Closed stock picks
No closed stock picks yet.
